Google introduced on Wednesday that it has obtained FDA clearance for the Pixel Watch 3’s “Lack of Pulse Detection” characteristic and can be launching it within the U.S. on the finish of March.
The characteristic can detect when a consumer’s coronary heart stops beating as a consequence of an occasion like major cardiac arrest, respiratory or circulatory failure, overdose, or poisoning. If the watch detects a lack of pulse, it can ask the consumer if they’re okay. If they’re unresponsive, the watch will routinely place a name to emergency providers for probably life-saving care.
Lack of Pulse Detection first launched within the EU in September 2024, and is presently obtainable in 14 international locations.
When Google introduced the characteristic eventually yr’s Made By Google occasion, the corporate famous that the watch determines a lack of pulse occasion by not solely checking a consumer’s pulse, however by additionally taking a look at different physiological and movement knowledge. It then ties these elements collectively by way of a wise AI-driven algorithm.
Google notes that “Lack of Pulse Detection could not detect each occasion of a lack of pulse and isn’t meant for customers with preexisting coronary heart circumstances or those that require cardiac monitoring. It doesn’t diagnose or deal with any medical situation or present follow-up care. Emergency calling depends on name performance resembling your cellphone or watch being charged and having ample mobile connectivity.”
The brand new characteristic joins Pixel Watch’s different security and well being options, together with Automotive Crash Detection, Fall Detection, Irregular Coronary heart Rhythm Notifications, and the ECG app.
